INAB
IN8BIO, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.09
−1.80%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.34
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.25
- EPS estimate
- -$0.34
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +42.9%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.34 | -$0.25 | Beat 27.26% | — |
| May 7, 2026 | -$0.59 | -$0.26 | Beat 55.93% | — |
| Mar 12, 2026 | -$0.64 | -$0.26 | Beat 59.41% | — |
| Nov 6, 2025 | -$1.20 | -$0.85 | Beat 29.17% | — |
| Aug 7, 2025 | -$1.50 | -$1.24 | Beat 17.33% | — |
| May 7, 2025 | -$1.80 | -$2.10 | Miss -16.67% | — |
| Mar 13, 2025 | -$0.07 | -$0.04 | Beat 42.86% | — |
| Aug 8, 2024 | -$0.16 | -$0.19 | Miss -18.75% | — |
| May 9, 2024 | -$0.17 | -$0.20 | Miss -17.65% | — |
| Mar 14, 2024 | -$0.16 | -$0.21 | Miss -31.25% | $3.7M |
| Nov 9, 2023 | -$0.25 | -$0.23 | Beat 8.00% | — |
| Aug 10, 2023 | -$0.28 | -$0.27 | Beat 3.57% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026